会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins
    • 前列腺素作为肉毒杆菌毒素B和破​​伤风神经毒素的特异性抑制剂和治疗剂
    • US07235521B1
    • 2007-06-26
    • US09979101
    • 2000-05-15
    • Richard K. GordonDeborah R. MooradBhupendra P. DoctorGregory E. Garcia
    • Richard K. GordonDeborah R. MooradBhupendra P. DoctorGregory E. Garcia
    • A61K38/00
    • C12Q1/37G01N2333/95G01N2500/00
    • The compounds of the invention are generally described by the formula (1): B1Z*2B3Z*4X*5Q6F7X8X9X10X11, (2): B1X2X3X4X5Q6F7X8X9X10X11, or (3): B1X2B3X4Z5Q6F7Z8X9X10X11 and the salts, esters, amides, and acyl forms thereof. Each position represented by a letter indicates a single amino acid residue: B is a basic or polar/large amino acid or a modified form thereof; X is a small or hydrophobic amino acid or a modified form thereof; X* is a small or polar/large amino acid or a modified form thereof; Z is a polar/large or hydrophobic amino acid or a modified form thereof; Z* is Proline or a polar/large or hydrophobic amino acid or a modified form thereof. As described below, one or more of the peptide linkages between the amino acid residues may be replaced by a peptide linkage mimic. These compounds may be used as molecular building blocks to create compounds that are optimized for inhibiting the protease activity of Botulinum B and tetanus toxins.
    • 本发明的化合物通常由式(1)描述:B 1 Z * 2 B 3 Z * 4 < 5×6×6×6××××××××××××××××××××××××××××××××××××××××××< (2):B 1 X 2 X 3 X 2 X 2 X 3 5 5 5 或(3):B 1 X 2 B 3 3 5 X 5 5 5 它们的盐,酯,酰胺和酰基形式。 由字母表示的每个位置表示单个氨基酸残基:B是碱性或极性/大氨基酸或其修饰形式; X是小或疏水性氨基酸或其修饰形式; X *是小或极/大氨基酸或其修饰形式; Z是极性/大或疏水性氨基酸或其修饰形式; Z *是脯氨酸或极性/大或疏水性氨基酸或其修饰形式。 如下所述,氨基酸残基之间的一个或多个肽键可以被肽键模拟物代替。 这些化合物可用作分子结构单元以产生针对抑制肉毒杆菌B和破伤风毒素的蛋白酶活性而优化的化合物。